HomeSentreHEART Inc

SentreHEART Inc

Clinical Use of the LARIAT® with EpiRAIL™ Procedure for Left Atrial Appendage Exclusion

The LARIAT with EpiRAIL is an epicardial-only, percutaneous approach to complete and permanent closure of the left atrial appendage in patients with atrial fibrillation & increased risk of stroke.

5/3/19: SentreHEART Receives CE Mark for LARIAT-RS™ 50mm and Expanded Indication for Left Atrial Appendage Exclusion

SentreHEART, Inc., announced it has received CE Mark for the LARIAT-RS ™ 50mm as well as expanded labeling for the LARIAT-RS for left atrial appendage (LAA) exclusion. The new 50mm device along with the 45mm LARIAT-RS is now available for sale in Europe.

SentreHEART Announces Participation at The American College of Cardiology’s 67th Annual Scientific Session & Expo

3/9/18: SentreHEART, Inc., the manufacturer of the LARIAT® Suture Delivery Device (LARIAT) will be participating in the American College of Cardiology 2018 meeting being held in Orlando, Florida, March 10-12, 2018.